Secukinumab Therapeutic Cheat Sheet
SecukinumabSecukinumab is a recombinant human monoclonal immunoglobulin IgG1κ antibody that selectively targets interleukin-17A (IL-17A), a key effector cytokine in the Th17 pathway implicated in the pathogenesis of psoriasis. With its high target specificity, rapid onset, sustained efficacy, and favorable safety profile, secukinumab has become a mainstay in the treatment of psoriasis and other inflammatory …
Secukinumab
Patient Buzz Series | Breast Milk as Skin Care
breast milk skin careA model and influencer is making news for using her sister’s breast milk as part of her skincare routine. According to an article in People magazine, Quenlin Blackwell uses the breast milk for baths and face masks. Dermatologist Dr. Naana Boakye said breast milk has shown potential for soothing inflammatory skin conditions as well as moisturizing and strengthening the skin barrier. Dr. Boakye re …
breast milk skin care
JDD June 2025 Issue Highlights | Special Focus: Acne & Rosacea
acneThe June 2025 issue of the Journal of Drugs in Dermatology delivers a diverse and thought-provoking selection of studies that place a spotlight on acne and rosacea while spanning the latest innovations and clinical insights across the dermatology spectrum. This month’s editor’s picks feature new approaches to some of the field’s most common—and challenging—conditions, from acne-induced …
acne
Friday Pop Quiz #328
The correct answer is D. Pemphigus gestationis. Pemphigoid gestationis (PG) is an autoimmune blistering disorder that typically presents with pruritic urticarial plaques and papules around the umbilicus, which can later generalize and form blisters. It often flares around the time of delivery and can recur in subsequent pregnancies. The diagnosis is supported by the presence of urticarial plaqu …
Friday Pop Quiz #326
The correct answer is D. Topical glucocorticoids. The image shows plaque type psoriasis. For mild to moderate disease, topical glucocorticoids are the 1st line therapy. Narrow-band UBV is the 1st line therapy for moderate to severe psoriasis Biologic agents are not first line therapy for mild to plaque moderate psoriasis Acitretin is effective in pustular and palmoplantar psoriasis and …
error

Enjoy this blog? Please spread the word :)